Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case report
- Author:
Seong Kyun NA
1
Author Information
- Publication Type:Case Report
- From:Journal of Liver Cancer 2022;22(2):178-182
- CountryRepublic of Korea
- Language:English
- Abstract: Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare malignant hepatic cancer with characteristics that differ from those of typical hepatocellular carcinoma (HCC). Unlike conventional HCC, FLHCC is common in young patients without any underlying liver disease and is known to be associated with a unique gene mutation. This cancer type is rare in Asia, with only a few cases being reported in Korea. We report a case of FLHCC in a young woman that successfully underwent surgical resection. The efficacy of alternative treatments, such as transarterial chemoembolization or systemic chemotherapies, has not yet been established. To conclude, early diagnosis and appropriate surgical resection are important for the treatment of FLHCC.
